Mifisure 25 Tablet is a prescription-only medication containing Mifepristone (25mg) as the active pharmaceutical ingredient. It is a selective progesterone receptor modulator indicated for the termination of intrauterine pregnancy in women with a gestational age up to 63 days. The product is also used for the treatment of uterine leiomyoma, also known as fibroids, in women of childbearing age. Mifisure 25 Tablet works by blocking the action of progesterone, a hormone essential for the maintenance of pregnancy, thereby leading to the termination of the pregnancy. In women with fibroids, the medication helps to reduce the size of the tumors. The product is available in tablet form and should be taken orally. The recommended dosage is a single tablet taken at the earliest possible time on the first day of menstruation or within 7 days of a missed period. It is essential to follow the patient information leaflet and the doctor's instructions carefully, as Mifisure 25 Tablet may not be suitable for all women.